Get the Stockscreener App
54.95
4.53%
-2.61
After Hours:
54.95
Akero Therapeutics Inc Stock (AKRO) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Research and Development |
5.14%
50.65
|
53.39 | 38.63 | 27.98 | 21.79 |
| Interest Income/Expense |
10.48%
0.991
|
0.897 | 0.888 | 0.857 | 0.457 |
| Operating Income/Loss |
3.10%
-59.95
|
-61.87 | -46.62 | -35.63 | -28.75 |
| Income/Loss From Continuing Operations Before Tax |
3.34%
-53.34
|
-55.19 | -39.66 | -31.08 | -25.83 |
| Income/Loss From Continuing Operations After Tax |
3.34%
-53.34
|
-55.19 | -39.66 | -31.08 | -25.83 |
Net Income/Loss
|
3.34%
-53.34
|
-55.19 | -39.66 | -31.08 | -25.83 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,488%
59.31
|
1.0614 | 55.61 | 51.87 | 46.94 |
| Diluted Average Shares |
5,488%
59.31
|
1.0614 | 55.61 | 51.87 | 46.94 |
| Basic Earnings Per Share |
11.76%
-0.90
|
-1.02 | -0.71 | -0.60 | -0.55 |
| Diluted Earnings Per Share |
11.76%
-0.90
|
-1.02 | -0.71 | -0.60 | -0.55 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):